Femke H. M. Prince

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

Peter A. Nigrović, Melissa L. Mannion, Femke H. M. Prince et al. · Arthritis & Rheumatism · 2010 · 464 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis

Dirk Holzinger, Michael Frosch, Astrid Kastrup et al. · Annals of the Rheumatic Diseases · 2012 · 163 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

Siri Lillegraven, Femke H. M. Prince, Nancy A. Shadick et al. · Annals of the Rheumatic Diseases · 2011 · 163 citations

Medicine, Diagnostic Sciences, Immunopathology +15

Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

M.H. Otten, Femke H. M. Prince, Wineke Armbrust et al. · JAMA · 2011 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Sustained rheumatoid arthritis remission is uncommon in clinical practice

Femke H. M. Prince, Vivian P. Bykerk, Nancy A. Shadick et al. · Arthritis Research & Therapy · 2012 · 100 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17